A. Zielinski

发表

Second-Generation Antiandrogen Therapy Radiosensitizes Prostate Cancer Regardless of Castration State through Inhibition of DNA Double Strand Break Repair

C. Bokemeyer, H. Huland, K. Rothkamm, 2020, Cancers.

DNA Damage Response during Replication Correlates with CIN70 Score and Determines Survival in HNSCC Patients

T. Clauditz, K. Rothkamm, S. Werner, 2021, Cancers.

PARP1 inhibition radiosensitizes HNSCC cells deficient in homologous recombination by disabling the DNA replication fork elongation response

T. Clauditz, A. Friedl, C. Petersen, 2016, Oncotarget.

Partial Reduction in BRCA1 Gene Dose Modulates DNA Replication Stress Level and Thereby Contributes to Sensitivity or Resistance

H. Pospiech, T. Liehr, K. Rothkamm, 2022, International journal of molecular sciences.

TSC loss distorts DNA replication programme and sensitises cells to genotoxic stress

H. Pospiech, Zhao-Qi Wang, G. Pai, 2016, Oncotarget.

Salvage Chemotherapy with Cisplatin, Ifosfamide, and Paclitaxel in Aggressive Variant of Metastatic Castration-Resistant Prostate Cancer

C. Bokemeyer, S. Perner, M. Graefen, 2022, International journal of molecular sciences.

Exploiting Chromosomal Instability of PTEN-Deficient Triple-Negative Breast Cancer Cell Lines for the Sensitization Against PARP1 Inhibition in a Replication-Dependent Manner

K. Rothkamm, H. Wikman, C. Petersen, 2020, Cancers.

The POLD1R689W variant increases the sensitivity of colorectal cancer cells to ATR and CHK1 inhibitors

T. Gress, M. Buchholz, E. Gallmeier, 2020, Scientific Reports.

S100A11 plays a role in homologous recombination and genome maintenance by influencing the persistence of RAD51 in DNA repair foci

H. Pospiech, F. Grosse, K. Mrasek, 2016, Cell cycle.